 The aim of this study is the comparison of the current standard R-CHOP followed by myeloablative radio-chemotherapy and subsequent blood stem cell transplantation to a new alternating induction regimen containing high dose Ara-C R-CHOPDHAP followed by a high dose ARA-C containing myeloablative radio-chemotherapy and PBSCT. 